Due to current HHS restructuring, the information provided on aspe.hhs.gov is not being updated currently. Please refer to hhs.gov for more information.

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Data Point: Savings Available Under Full Generic Substitution of Multiple Source Brand Drugs in Medicare Part D

Publication Date

Jul 22, 2018

ASPE analyzed Part D prescription drug event data from 2016 to estimate spending on brand drugs with generic therapeutic equivalents.

Files

DP-Multisource-Brands-in-Part-D.pdf (pdf, 248.35 KB)

Topics

Prescription Drugs | Health Insurance | Drug Pricing

Product Type

ASPE Data Point

Populations

Medicare Beneficiaries

Program

Medicare Part D | Medicare

Data Point: Savings Available Under Full Generic Substitution of Multiple Source Brand Drugs in Medicare Part D

Connect with Us